Mainz Biomed N.V. announced distribution partnership with Praxisdienst, Germany?s larger online retailer for medical products. This collaboration, which commenced in February 2024, marks an important step in Mainz Biomed?s mission to enhance healthcare delivery across Germany, focusing on the accessibility of their product, ColoAlert®. ColoAlert® represents a breakthrough in the early detection of colorectal cancer, offering a convenient, non-invasive at-home stool test that goes beyond traditional screening methods.

Unlike standard tests that only detect the presence of blood in the stool, ColoAlert® utilizes advanced technology to identify tumor DNA, providing a more comprehensive screening option. This innovative approach ensures higher detection rates, especially in cases where tumors do not bleed, thereby facilitating the early diagnosis of colorectal cancer. Early detection is crucial, as it significantly enhances the treatability of this condition, potentially saving lives.

This partnership will harness Praxisdienst's extensive distribution network alongside Mainz Biomed's diagnostic technologies, ensuring broader access to their sophisticated medical solutions for healthcare professionals and patients throughout Germany.